Asia shares rose on Thursday, tracking gains on Wall Street following a see-saw session, while US Treasury yields came under pressure after mixed economic data.
On the winning side of Wall Street were Novo Nordisk’s U.S.-listed shares, which jumped 8.6%. The Danish company reported results from a clinical trial of a treatment for people who are overweight or ...